Your browser doesn't support javascript.
loading
Does Timing of Antihypertensive Medication Dosing Matter?
Hermida, Ramón C; Hermida-Ayala, Ramón G; Smolensky, Michael H; Mojón, Artemio; Crespo, Juan J; Otero, Alfonso; Ríos, María T; Domínguez-Sardiña, Manuel; Fernández, José R.
Afiliação
  • Hermida RC; Bioengineering & Chronobiology Laboratories, Atlantic Research Center for Information and Communication Technologies (atlanTTic);, University of Vigo, 36310, Vigo, Spain. rhermida@uvigo.es.
  • Hermida-Ayala RG; Department of Biomedical Engineering, Cockrell School of Engineering,, The University of Texas at Austin, Austin, TX, 78712-0238, USA. rhermida@uvigo.es.
  • Smolensky MH; Circadian Ambulatory Technology & Diagnostics (CAT&D), 15703, Santiago de Compostela, Spain.
  • Mojón A; Department of Biomedical Engineering, Cockrell School of Engineering,, The University of Texas at Austin, Austin, TX, 78712-0238, USA.
  • Crespo JJ; Bioengineering & Chronobiology Laboratories, Atlantic Research Center for Information and Communication Technologies (atlanTTic);, University of Vigo, 36310, Vigo, Spain.
  • Otero A; Bioengineering & Chronobiology Laboratories, Atlantic Research Center for Information and Communication Technologies (atlanTTic);, University of Vigo, 36310, Vigo, Spain.
  • Ríos MT; Estructura de Xestión Integrada de Vigo, Servicio Galego de Saúde (SERGAS), 36214, Vigo, Spain.
  • Domínguez-Sardiña M; Servicio de Nefrología, Complejo Hospitalario Universitario de Ourense, Estructura de Xestión Integrada de Ourense, Verín e O Barco de Valdeorras, Servicio Galego de Saúde (SERGAS), 32005, Ourense, Spain.
  • Fernández JR; Bioengineering & Chronobiology Laboratories, Atlantic Research Center for Information and Communication Technologies (atlanTTic);, University of Vigo, 36310, Vigo, Spain.
Curr Cardiol Rep ; 22(10): 118, 2020 08 09.
Article em En | MEDLINE | ID: mdl-32772186
ABSTRACT
PURPOSE OF REVIEW Current hypertension guidelines do not provide recommendation on when-to-treat. Herein, we review the current evidence on ingestion-time differences of hypertension medications in blood pressure (BP)-lowering effects and prevention of cardiovascular disease (CVD) events. RECENT

FINDINGS:

The vast (81.6%) majority of the 136 published short-term treatment-time trials document benefits, including enhanced reduction of asleep BP and increased sleep-time relative BP decline (dipping), when hypertension medications and their combinations are ingested before sleep rather than upon waking. Long-term outcome trials further document bedtime hypertension therapy markedly reduces risk of major CVD events. The inability of the very small 18.4% of the published trials to substantiate treatment-time difference in effects is mostly explained by deficiencies of study design and conduct. Our comprehensive review of the published literature reveals no single study has reported better benefits of the still conventional, yet scientifically unjustified, morning than bedtime hypertension treatment scheme.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hipertensão / Anti-Hipertensivos Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Curr Cardiol Rep Assunto da revista: CARDIOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hipertensão / Anti-Hipertensivos Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Curr Cardiol Rep Assunto da revista: CARDIOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha